-
- Hayashi Yasuhiro
- Faculty of Agriculture, University of Miyazaki
-
- Matsuda Kouki
- Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute
-
- Tanigawa Kazunari
- Faculty of Pharma-Sciences, Teikyo University
-
- Tanikawa Takashi
- Faculty of Pharmacy and Pharmaceutical Sciences, Josai University
-
- Maeda Kenji
- Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University
-
- Tsuchiya Kiyoto
- AIDS Clinical Center, National Center for Global Health and Medicine
この論文をさがす
説明
<p>Dihydroceramide Δ4-desaturase 1 (DEGS1) enzymatic activity is inhibited with N-(4-hydroxyphenyl)-retinamide (4-HPR). We reported previously that 4-HPR suppresses severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry through a DEGS1-independent mechanism. However, it remains unclear whether DEGS1 is involved in other SARS-CoV-2 infection processes, such as virus replication and release. Here we established DEGS1 knockout (KO) in VeroE6TMPRSS2 cells. No significant difference was observed in virus production in the culture supernatant between wild-type (WT) cells and DEGS1-KO cells, although the levels of dihydroceramide (DHCer), a DEGS1 substrate, were significantly higher in DEGS1-KO cells than WT cells. Furthermore, the virus-induced cytopathic effect was also observed in DEGS1-KO cells. Importantly, the EC50 value of 4-HPR in DEGS1-KO cells was almost identical to the value reported previously in WT cells. Our results indicated the lack of involvement of DEGS1 in SARS-CoV-2 infection.</p>
収録刊行物
-
- Ｂｉｏｌｏｇｉｃａｌ ＆ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｂｕｌｌｅｔｉｎ
-
Ｂｉｏｌｏｇｉｃａｌ ＆ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｂｕｌｌｅｔｉｎ 45 (10), 1559-1563, 2022-10-01
公益社団法人 日本薬学会
